title: Does naloxone reinstate secondary hyperalgesia in humans after resolution of a burn injury? A placebo-controlled, double-blind, randomized, cross-over study.
abstract: BACKGROUND
  Development of secondary hyperalgesia following a cutaneous injury is a centrally mediated, robust phenomenon. The pathophysiological role of endogenous opioid signalling to the development of hyperalgesia is unclear. Recent animal studies, carried out after the resolution of inflammatory pain, have demonstrated reinstatement of tactile hypersensitivity following administration of μ-opioid-receptor-antagonists. In the present study in humans, we analyzed the effect of naloxone when given after the resolution of secondary hyperalgesia following a first-degree burn injury.
  
  
  METHODS
  Twenty-two healthy volunteers were included in this placebo-controlled, randomized, double-blind, cross-over study. Following baseline assessment of thermal and mechanical thresholds, a first-degree burn injury (BI; 47°C, 7 minutes, thermode area 12.5 cm(2)) was induced on the lower leg. Secondary hyperalgesia areas around the BI-area, and separately produced by brief thermal sensitization on the contralateral thigh (BTS; 45°C, 3 minutes, area 12.5 cm(2)), were assessed using a polyamide monofilament at pre-BI and 1, 2, and 3 hours post-BI. At 72 hrs, BI and BTS secondary hyperalgesia areas were assessed prior to start of a 30 minutes intravenous infusion of naloxone (total dose 21 microg/kg) or placebo. Fifteen minutes after start of the infusion, BI and BTS secondary hyperalgesia areas were reassessed, along with mechanical and thermal thresholds.
  
  
  RESULTS
  Secondary hyperalgesia areas were demonstrable in all volunteers 1-3 hrs post-BI, but were not demonstrable at 72 hrs post-burn in 73-86% of the subjects. Neither magnitude of secondary hyperalgesia areas nor the mechanical and thermal thresholds were associated with naloxone-treated compared to placebo-treated subjects.
  
  
  CONCLUSIONS
  Naloxone (21 microg/kg) did not reinstate secondary hyperalgesia when administered 72 hours after a first-degree burn injury and did not increase BTS-generated hyperalgesia. The negative results may be due to the low dose of naloxone or insufficient tissue injury to generate latent sensitization.
authors.affiliation: Neuroscience Center, Rigshospitalet, Copenhagen University Hospitals, Copenhagen, Denmark. mpflp47@gmail.com
authors.forename: Manuel P
authors.initials: MP
authors.lastname: Pereira
authors.forename: Mads U
authors.initials: MU
authors.lastname: Werner
authors.forename: Thomas K
authors.initials: TK
authors.lastname: Ringsted
authors.forename: Michael C
authors.initials: MC
authors.lastname: Rowbotham
authors.forename: Bradley K
authors.initials: BK
authors.lastname: Taylor
authors.forename: Joergen B
authors.initials: JB
authors.lastname: Dahl
mesh_terms: D000328:Adult; D000818:Animals; D002056:Burns / Q000150:complications / Q000503:physiopathology* / Q000523:psychology; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006930:Hyperalgesia / Q000209:etiology / Q000503:physiopathology* / Q000523:psychology; D008297:Male; D009270:Naloxone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D017288:Pain Threshold / Q000187:drug effects*; D010919:Placebos
chemical_list: D009292:Narcotic Antagonists; D010919:Placebos; D009270:Naloxone